Virtual Reality and Cranial Nerve Neuromodulation for Chronic Pain
(VR & CN-NINM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help veterans manage chronic pain and PTSD using virtual reality (VR) and cranial nerve non-invasive neuromodulation (CN-NINM). The study will test VR alone, a combination of VR with CN-NINM, and a placebo version of these treatments to determine which best reduces pain and calms the nervous system. Veterans with chronic pain lasting more than six months and diagnosed PTSD are ideal candidates for this trial. The goal is to find a more effective treatment to improve daily life for those affected. As an unphased trial, this study offers veterans the chance to contribute to groundbreaking research that could lead to innovative treatments for chronic pain and PTSD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this technique is safe for veterans with chronic pain and PTSD?
Research has shown that virtual reality (VR) is a safe and well-accepted method for managing long-term pain. Patients typically have positive experiences with VR, and it effectively lowers pain levels and anxiety. No major safety issues have been reported, making it a good option for pain relief.
Cranial nerve non-invasive neuromodulation (CN-NINM) is another treatment under study. Early results suggest that CN-NINM is practical and might improve functions in various conditions. It stimulates the tongue, which can calm the part of the nervous system controlling automatic actions like heartbeat. Although its impact on pain is currently small, studies so far have considered it safe.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for chronic pain because they explore innovative approaches beyond traditional medications like opioids, NSAIDs, or physical therapy. The combination of cranial nerve non-invasive neuromodulation (CN-NINM) with virtual reality (VR) offers a unique, non-drug method that targets pain through neural pathways and immersive distraction. Unlike standard treatments, CN-NINM aims to modulate pain signals directly via the cranial nerves, while the VR component provides a calming, immersive environment that may enhance pain relief through relaxation and hypnotic suggestions. This dual approach could offer a safer, more holistic alternative for managing chronic pain, potentially reducing reliance on pharmaceuticals and improving quality of life.
What evidence suggests that this trial's treatments could be effective for chronic pain and PTSD?
Research has shown that virtual reality (VR), one of the treatments in this trial, can effectively reduce pain and improve related outcomes. Studies have found that VR lowers pain levels, reduces anxiety, and lessens pain's impact on daily life. It also boosts mood and sleep quality. Notably, 78% of clinical trials found VR helpful for pain relief.
Another treatment option in this trial is cranial nerve non-invasive neuromodulation (CN-NINM). New evidence suggests it can help with chronic pain by encouraging the brain to adapt and change. Although research is ongoing, CN-NINM has improved balance and walking when combined with physical therapy.
This trial will explore the potential benefits of combining VR with CN-NINM, which might enhance pain relief and offer a promising new way to manage chronic pain and PTSD.46789Who Is on the Research Team?
Guillaume Léonard, PhD
Principal Investigator
Université de Sherbrooke
Are You a Good Fit for This Trial?
This trial is for Canadian veterans experiencing chronic pain and PTSD. Participants should be interested in trying non-invasive treatments like virtual reality and tongue stimulation techniques to manage their symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive VR, VR + CN-NINM, and VR + sham CN-NINM interventions, each for 20 minutes
Follow-up
Participants are monitored for changes in pain intensity, ANS reactivity, and other measures
Data Analysis and Reporting
Data collected from interventions and follow-up are analyzed to assess efficacy
What Are the Treatments Tested in This Trial?
Interventions
- Cranial Nerve Non-Invasive Neuromodulation (CN-NINM)
- Placebo CN-NINM
- Virtual Reality
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor
Chronic Pain Center of Excellence for Canadian Veterans
Collaborator
Quebec Pain Research Network
Collaborator